Patients and HCPs main concerns re: biosimilars are less efficacy and being forced to switch @RheumNow #ACR18 https://t.co/wDBpxzpPE5
Links:
Oct-23-2018
Search for Terms or Answers
Links:
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.